Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.6996
H.R.6996: Accelerating Access for Patients Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 8, 2022
- Latest Major Action March 9, 2022
Bill Sponsor
Bill Version
- Introduced in House - March 8, 2022
Bill Summary
Accelerating Access for Patients Act of 2022 This bill modifies requirements relating to accelerated approval of drugs for serious or life-threatening diseases or conditions, including by requiring guidance from the Food and Drug Administration and coordinated plans with product sponsors on appropriate postapproval studies.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 9, 2022 |
Referred to the Subcommittee on Health.
|
March 8, 2022 |
Referred to the House Committee on Energy and Commerce.
|
March 8, 2022 |
Introduced in the House by Cathy McMorris Rodgers (R-Wash.) |